Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Histological and Clinical Biomarkers to Predict the Progression of IgA Nephropathy

NCT02529722 is registered in ClinicalTrials.gov with Istanbul University as lead sponsor.

NCT NCT02529722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02529722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Histological and Clinical Biomarkers to Predict the Progression of IgA Nephropathy
Lead sponsor
Istanbul University
Phase
Observational
Overall status
Completed
Start date
January 31, 2012
Completion date
April 30, 2015
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glomerular diseases, iga nephropathy